Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?

Alessandra Pulvirenti; Georgios A. Margonis; Vicente Morales-Oyarvide; Caitlin A. McIntyre; Sharon A. Lawrence; Debra A. Goldman; Mithat Gonen; Matthew J. Weiss; Cristina R. Ferrone; Jin He; Murray F. Brennan; T. Peter Kingham; Vinod P. Balachandran; Michael I. D’Angelica; William R. Jarnagin

doi:https://doi.org/10.1097/sla.0000000000003703

doi.org/10.1097/sla.0000000000003703

Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?

Alessandra Pulvirenti

14

,

Georgios A. Margonis

35

,

..., William R. Jarnagin

102

Annals of Surgery9.00

Volume: 274, Issue: 6, Pages: e980 - e987

Published: Dec 4, 2019

Abstract

To evaluate the influence of consensus guidelines on the management of intraductal papillary mucinous neoplasms (IPMN) and the subsequent changes in pathologic outcomes.Over time, multiple guidelines have been developed to identify high-risk IPMN. We hypothesized that the development and implementation of guidelines should have increased the percentage of resected IPMN with high-risk disease.Memorial Sloan-Kettering (MSK), Johns Hopkins (JH),...